# My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia

> **NCT00801580** · PHASE2 · UNKNOWN · sponsor: **University of Bologna** · enrollment: 3 (estimated)

## Conditions studied

- Lymphoid Leukemia

## Interventions

- **DRUG:** doxorubicin liposomal

## Key facts

- **NCT ID:** NCT00801580
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2009-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801580, "My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00801580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*